Bisphenol A Accelerates Toxic Amyloid Formation of Human Islet Amyloid Polypeptide: a Possible Link Between Bisphenol A Exposure and Type 2 Diabetes
Overview
Affiliations
Bisphenol A (BPA) is a chemical compound widely used in manufacturing plastic products. Recent epidemiological studies suggest BPA exposure is positively associated with the incidence of type 2 diabetes mellitus (T2DM), however the mechanisms underlying this link remain unclear. Human islet amyloid polypeptide (hIAPP) is a hormone synthesized and secreted by the pancreatic β-cells. Misfolding of hIAPP into toxic oligomers and mature fibrils can disrupt cell membrane and lead to β-cell death, which is regarded as one of the causative factors of T2DM. To test whether there are any connections between BPA exposure and hIAPP misfolding, we investigated the effects of BPA on hIAPP aggregation using thioflavin-T based fluorescence, transmission electronic microscopy, circular dichroism, dynamic light scattering, size-exclusion chromatography, fluorescence-dye leakage assay in an artificial micelle system and the generation of reactive oxygen species in INS-1 cells. We demonstrated that BPA not only dose-dependently promotes the aggregation of hIAPP and enhances the membrane disruption effects of hIAPP, but also promotes the extent of hIAPP aggregation related oxidative stress. Taken together, our results suggest that BPA exposure increased T2DM risk may involve the exacerbated toxic aggregation of hIAPP.
Rishisree A, Mallory B, Elena K, Teodora J, Gordana Z, Katarina S Biophys Chem. 2023; 304:107130.
PMID: 37952497 PMC: 10841580. DOI: 10.1016/j.bpc.2023.107130.
Jiang W, Ding K, Huang W, Xu F, Lei M, Yue R Heliyon. 2023; 9(5):e16340.
PMID: 37251906 PMC: 10213369. DOI: 10.1016/j.heliyon.2023.e16340.
Endocrine disruptors in plastics alter β-cell physiology and increase the risk of diabetes mellitus.
Martinez-Pinna J, Sempere-Navarro R, Medina-Gali R, Fuentes E, Quesada I, Sargis R Am J Physiol Endocrinol Metab. 2023; 324(6):E488-E505.
PMID: 37134142 PMC: 10228669. DOI: 10.1152/ajpendo.00068.2023.
Endocrine disruptor chemicals as obesogen and diabetogen: Clinical and mechanistic evidence.
Kursunoglu N, Sarer Yurekli B World J Clin Cases. 2022; 10(31):11226-11239.
PMID: 36387809 PMC: 9649566. DOI: 10.12998/wjcc.v10.i31.11226.
George M, Leavens K, Gadue P Front Endocrinol (Lausanne). 2021; 12:682625.
PMID: 34149620 PMC: 8206553. DOI: 10.3389/fendo.2021.682625.